Mangoceuticals (MGRX) Return on Equity (2023 - 2025)
Historic Return on Equity for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 1.13%.
- Mangoceuticals' Return on Equity fell 4500.0% to 1.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.13%, marking a year-over-year decrease of 4500.0%. This contributed to the annual value of 1.18% for FY2024, which is N/A changed from last year.
- Mangoceuticals' Return on Equity amounted to 1.13% in Q3 2025, which was down 4500.0% from 0.72% recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' Return on Equity ranged from a high of 98.19% in Q1 2024 and a low of 8.65% during Q4 2023
- Over the past 3 years, Mangoceuticals' median Return on Equity value was 0.7% (recorded in 2025), while the average stood at 10.54%.
- In the last 5 years, Mangoceuticals' Return on Equity soared by 80100bps in 2024 and then crashed by -988400bps in 2025.
- Over the past 3 years, Mangoceuticals' Return on Equity (Quarter) stood at 8.65% in 2023, then skyrocketed by 93bps to 0.64% in 2024, then tumbled by -78bps to 1.13% in 2025.
- Its Return on Equity stands at 1.13% for Q3 2025, versus 0.72% for Q2 2025 and 0.65% for Q1 2025.